These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 28602366)

  • 1. Treatment of Heart Failure with Abnormal Left Ventricular Systolic Function in Older Adults.
    Aronow WS
    Heart Fail Clin; 2017 Jul; 13(3):467-483. PubMed ID: 28602366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left ventricular diastolic heart failure with normal left ventricular systolic function in older persons.
    Aronow WS
    J Lab Clin Med; 2001 May; 137(5):316-23. PubMed ID: 11329528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update of treatment of heart failure with reduction of left ventricular ejection fraction.
    Aronow WS
    Arch Med Sci Atheroscler Dis; 2016; 1(1):e106-e116. PubMed ID: 28905031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology, pathophysiology, prognosis, and treatment of systolic and diastolic heart failure in elderly patients.
    Aronow WS
    Heart Dis; 2003; 5(4):279-94. PubMed ID: 12877761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. American College of Cardiology/American Heart Association Chronic Heart Failure Evaluation and Management guidelines: relevance to the geriatric practice.
    Ahmed A
    J Am Geriatr Soc; 2003 Jan; 51(1):123-6. PubMed ID: 12534856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of increased dose of diuretics on symptoms, weight, 6-minute walk distance, and echocardiographic measurements of left ventricular systolic and diastolic function in 51 patients with symptomatic heart failure caused by reduced left ventricular ejection fraction treated with beta blockers and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.
    Kumar A; Aronow WS; Vadnerkar A; Sivan K; Mittal S
    Am J Ther; 2009; 16(1):5-7. PubMed ID: 19142162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current treatment of heart failure with reduction of left ventricular ejection fraction.
    Aronow WS
    Expert Rev Clin Pharmacol; 2016 Dec; 9(12):1619-1631. PubMed ID: 27673415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Congestive heart failure: what should be the initial therapy and why?
    Chatterjee K
    Am J Cardiovasc Drugs; 2002; 2(1):1-6. PubMed ID: 14727993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of systolic and diastolic heart failure in the elderly.
    Aronow WS
    J Am Med Dir Assoc; 2006 Jan; 7(1):29-36. PubMed ID: 16413432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart Failure Complicating Acute Mtyocardial Infarction.
    Aronow WS
    Heart Fail Clin; 2017 Jul; 13(3):513-525. PubMed ID: 28602369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of heart failure with abnormal left ventricular systolic function in the elderly.
    Aronow WS
    Clin Geriatr Med; 2007 Feb; 23(1):61-81. PubMed ID: 17126755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: review of trials and practical considerations.
    Klein L; O'Connor CM; Gattis WA; Zampino M; de Luca L; Vitarelli A; Fedele F; Gheorghiade M
    Am J Cardiol; 2003 May; 91(9A):18F-40F. PubMed ID: 12729848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of heart failure with normal left ventricular ejection fraction.
    Aronow WS
    Compr Ther; 2007; 33(4):223-30. PubMed ID: 18025614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug treatment of systolic and of diastolic heart failure in elderly persons.
    Aronow WS
    J Gerontol A Biol Sci Med Sci; 2005 Dec; 60(12):1597-605. PubMed ID: 16424295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart failure update: treatment of heart failure with a normal left ventricular ejection fraction in the elderly.
    Aronow WS
    Geriatrics; 2006 Aug; 61(8):16-20. PubMed ID: 16901193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omecamtiv Mecarbil: A Novel Mechanistic and Therapeutic Approach to Chronic Heart Failure Management.
    Patel PH; Nguyen M; Rodriguez R; Surani S; Udeani G
    Cureus; 2021 Jan; 13(1):e12419. PubMed ID: 33542867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey.
    Cohen Solal A; Leurs I; Assyag P; Beauvais F; Clerson P; Contre C; Thebaut JF; Genoun M;
    Arch Cardiovasc Dis; 2012; 105(6-7):355-65. PubMed ID: 22800720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized, double-blind, multicenter, placebo-controlled study evaluating the effect of aldosterone antagonism with eplerenone on ventricular remodeling in patients with mild-to-moderate heart failure and left ventricular systolic dysfunction.
    Udelson JE; Feldman AM; Greenberg B; Pitt B; Mukherjee R; Solomon HA; Konstam MA
    Circ Heart Fail; 2010 May; 3(3):347-53. PubMed ID: 20299607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of medical therapy dosing in outpatients cared for in cardiology practices with heart failure and reduced ejection fraction with and without device therapy: report from IMPROVE HF.
    Heywood JT; Fonarow GC; Yancy CW; Albert NM; Curtis AB; Gheorghiade M; Inge PJ; McBride ML; Mehra MR; O'Connor CM; Reynolds D; Walsh MN
    Circ Heart Fail; 2010 Sep; 3(5):596-605. PubMed ID: 20634483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discharge use of angiotensin receptor blockers provides comparable effects with angiotensin-converting enzyme inhibitors on outcomes in patients hospitalized for heart failure.
    Tsuchihashi-Makaya M; Furumoto T; Kinugawa S; Hamaguchi S; Goto K; Goto D; Yamada S; Yokoshiki H; Takeshita A; Tsutsui H;
    Hypertens Res; 2010 Mar; 33(3):197-202. PubMed ID: 19960016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.